An Open-label, Phase I study to evaluate the drug-drug interaction of GS-9674 in healthy volunteers

Trial Profile

An Open-label, Phase I study to evaluate the drug-drug interaction of GS-9674 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs GS 9674 (Primary) ; Atorvastatin; Ciclosporin; Dabigatran etexilate; Gemfibrozil; Midazolam; Pravastatin; Rifampicin; Rosuvastatin; Voriconazole
  • Indications Non-alcoholic steatohepatitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 10 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top